Source:http://linkedlifedata.com/resource/pubmed/id/10553106
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1999-12-2
|
pubmed:abstractText |
The origin of the increased numbers of CD8+ atypical lymphocytes, expressing activated markers such as HLA-DR or CD45RO, in the peripheral blood of patients with infectious mononucleosis (IM) has been debated. Using a recently developed assay to detect intracellular accumulation of IFN-gamma in EBV-reactive T cells by FACS, we have demonstrated that 34-54% of HLA-DR+/CD8+ and 34-60% of CD45RO+/CD8+ T cells in the PBMCs of febrile patients suffering from IM are EBV-specific. The EBV-specific CD8+ T cell counts in the PBMCs of four febrile patients suffering from IM ranged between 2,260 and 8,200/microl, decreasing to 5.1% and 7.9% of the counts in the first samples over 10 days in two donors. The decline of CD8+ T cell subpopulations, namely HLA-DR+, CD45RO+, and EBV-specific T cells, was in parallel with the drop in the EBV genome load. These data indicate that the Ag-driven expansion of CD8+ T cells and subsequent contraction with the Ag decline in vivo in humans is effective for clearing virus-infected cells with minimal disturbance of the homeostasis of the immune system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD45,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5735-40
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10553106-Antigens, CD45,
pubmed-meshheading:10553106-Antigens, Viral,
pubmed-meshheading:10553106-CD8-Positive T-Lymphocytes,
pubmed-meshheading:10553106-Cell Separation,
pubmed-meshheading:10553106-Epitopes, T-Lymphocyte,
pubmed-meshheading:10553106-Genome, Viral,
pubmed-meshheading:10553106-HLA-DR Antigens,
pubmed-meshheading:10553106-Herpesvirus 4, Human,
pubmed-meshheading:10553106-Histocompatibility Antigens Class I,
pubmed-meshheading:10553106-Humans,
pubmed-meshheading:10553106-Infectious Mononucleosis,
pubmed-meshheading:10553106-Interferon-gamma,
pubmed-meshheading:10553106-Lymphocyte Activation,
pubmed-meshheading:10553106-Viral Load
|
pubmed:year |
1999
|
pubmed:articleTitle |
Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection.
|
pubmed:affiliation |
Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|